Skip to : [Content] [Navigation]
 
MD&DI July Newsletter
Tuesday, July 3, 2007
 

A New Approach to Pediatric Devices


Medical devices are designed and tested for adults. But children's bodies are different, and many adult devices don't work as well, or at all, on children. How to use devices in children is a problem that has vexed medical device manufacturers and caregivers for decades.

Up until now, the options for pediatric-use devices were not great. Either a device company could run expensive pediatric studies, or it could do nothing but sit back and watch hospital personnel improvise ways to use their products on children. So, a firm had to be either fully invested in a costly process that may not produce results, or it could do nothing and be vulnerable to potential misuse and abuse of its products. If there were a systematic way to retrofit devices for children, that might cut down on misuse and allow for more input by device companies.

Now, there might be. In June, as reported on MD&DI's blog, a nonprofit organization was launched to tackle those issues. Among the goals of the Institute for Pediatric Innovation is to work with children's hospitals to redesign devices to better fit children. The institute is based in Cambridge, MA, and its first three hospital partners are based in California, Kansas, and Ohio. As the institute's projects get launched, it will be important for device manufacturers to become familiar with them. As time goes on, it is likely that getting more actively involved with these projects will benefit industry.

Also, the Institute for Pediatric Innovation and similar nonprofits stand to benefit from language in the version of the FDA Revitalization Act passed by a House of Representatives subcommittee last month. Congress would give such organizations $6 million per year for the next five years. It would also provide the device industry with something already in place for the drug industry: patent extensions in exchange for performing pediatric studies. Finally, it would allow device companies to price such devices high enough to make a profit, provided volume was 4000 per year or fewer.

These are badly needed incentives that could give device manufacturers more reasons to design pediatric devices or study the performance of their devices in children. The first step that industry should take is to lobby to ensure that such language remains in the version of the bill that ultimately gets passed.

Erik Swain
erik.swain@cancom.com






Neurotechnology
Neurotechnology Offers Relief and Recovery
By Sherrie Conroy
Advances in ways to treat neurological disorders are giving hope to people who have not been able to find relief via traditional therapy.

Coatings

Coatings Cover Many Bases for Device Makers
By William Leventon
New ways of mixing and applying coatings to devices enables them to serve multiple purposes.

Precision Technology

Grinding and Polishing Orthopedic Implants
By Ed Reitz
Selecting the right abrasive for metal medical prostheses is key to the finished implant. Here's how to make the right choice.

Clinical Trials

Best of Both Worlds: SOPs for Device Trials in Europe, Part 2
By Nancy J. Stark
Performing clinical trials in Europe may require creating a hybrid procedure from both ISO 14155 and the ICH-GCPs.

Product Development Insight

Design Research Part 2: Refining User Interfaces
By Bill Evans
Once a design team has a few ideas for a design, it's important to get user feedback and translate it into the final UI specification.

More from this issue of MD&DI

 

Tips for Writing SOPs
Developing and managing procedures isn't easy in a regulated environment. OEMs should look to their actual processes when writing SOPs.




Check Out MD&DI's Blog
Intravascular ultrasound technology has been around for about 10 years, but many doctors haven’t seen it as necessary. That may be changing now that it has been found to provide better views of stent placements than angiograms. The technology enables cardiologists to see whether the stent has been fully expanded against the artery wall; angiograms can’t do that. With the many fears about drug-eluting stents causing clots, this could prompt a shift in industry.

Send your suggestions, comments, and inquiries to the editors.

Subscription Information:
For more information about subscribing to MD&DI, click here.

Advertising Information:
For more information about advertising in MD&DI or in the MD&DI E-Mail Update, contact the MD&DI Sales Manager.


©2007 Canon Communications 11444 West Olympic Blvd., Los Angeles, CA 90064
If you feel you have received this message in error, or wish to be removed from future communications, please REMOVE ME